(Q39877047)

15 September 2017

title

Development of inducible EIAV-based lentiviral vector packaging and producer cell lines (English)

1 reference

15 September 2017

H J Stewart

1

1 reference

15 September 2017

M A Leroux-Carlucci

2

1 reference

15 September 2017

C J M Sion

3

1 reference

15 September 2017

K A Mitrophanous

4

1 reference

15 September 2017

P A Radcliffe

5

1 reference

15 September 2017

language of work or name

1 reference

5 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

805-814

1 reference

Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Stable gene transfer to the nervous system using a non-primate lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Gene transfer system derived from the caprine arthritis-encephalitis lentivirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Sustained transduction of ocular cells with a bovine immunodeficiency viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Analysis of factor VIII mediated suppression of lentiviral vector titres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A new-generation stable inducible packaging cell line for lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Continuous high-titer HIV-1 vector production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A stable system for the high-titer production of multiply attenuated lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Altering the tropism of lentiviral vectors through pseudotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Effects of stoichiometry of retroviral components on virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Efficient production of germline transgenic chickens using lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Mechanisms underlying expression of Tn10 encoded tetracycline resistance

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.20

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2009.20

1 reference

15 September 2017

1 reference